Recent work in healthy individuals has demonstrated the ubiquity of mutations known to co‐occur in FLT3‐ITD mutated AML, as well as age‐dependent expansion of cell populations characterised by such mutations, including DNMT3A and TET2 [66, 67, 68]. Here, TET2 is linked to acute myeloid leukemia.